Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319443485> ?p ?o ?g. }
- W4319443485 endingPage "3226" @default.
- W4319443485 startingPage "3226" @default.
- W4319443485 abstract "Immune checkpoint inhibitors (ICIs) have a modest clinical activity when administered as monotherapy against breast cancer (BC), the most common malignancy in women. Novel combinatorial strategies are currently being investigated to overcome resistance to ICIs and promote antitumor immune responses in a greater proportion of BC patients. Recent studies have shown that the BC abnormal vasculature is associated with immune suppression in patients, and hampers both drug delivery and immune effector cell trafficking to tumor nests. Thus, strategies directed at normalizing (i.e., at remodeling and stabilizing) the immature, abnormal tumor vessels are receiving much attention. In particular, the combination of ICIs with tumor vessel normalizing agents is thought to hold great promise for the treatment of BC patients. Indeed, a compelling body of evidence indicates that the addition of low doses of antiangiogenic drugs to ICIs substantially improves antitumor immunity. In this review, we outline the impact that the reciprocal interactions occurring between tumor angiogenesis and immune cells have on the immune evasion and clinical progression of BC. In addition, we overview preclinical and clinical studies that are presently evaluating the therapeutic effectiveness of combining ICIs with antiangiogenic drugs in BC patients." @default.
- W4319443485 created "2023-02-09" @default.
- W4319443485 creator A5024722868 @default.
- W4319443485 creator A5035757564 @default.
- W4319443485 creator A5039390544 @default.
- W4319443485 creator A5044044754 @default.
- W4319443485 creator A5047896093 @default.
- W4319443485 creator A5054281668 @default.
- W4319443485 creator A5061484089 @default.
- W4319443485 creator A5073730516 @default.
- W4319443485 creator A5080546971 @default.
- W4319443485 creator A5085756513 @default.
- W4319443485 creator A5088553151 @default.
- W4319443485 date "2023-02-06" @default.
- W4319443485 modified "2023-09-26" @default.
- W4319443485 title "The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies" @default.
- W4319443485 cites W1531194977 @default.
- W4319443485 cites W1564674105 @default.
- W4319443485 cites W1641237256 @default.
- W4319443485 cites W1665704747 @default.
- W4319443485 cites W1798615689 @default.
- W4319443485 cites W1966063402 @default.
- W4319443485 cites W1967441007 @default.
- W4319443485 cites W1971324461 @default.
- W4319443485 cites W1978139448 @default.
- W4319443485 cites W1985804036 @default.
- W4319443485 cites W1992112921 @default.
- W4319443485 cites W1992560794 @default.
- W4319443485 cites W1993519783 @default.
- W4319443485 cites W1994993231 @default.
- W4319443485 cites W1995749507 @default.
- W4319443485 cites W1996213381 @default.
- W4319443485 cites W2001717792 @default.
- W4319443485 cites W2004575520 @default.
- W4319443485 cites W2006202974 @default.
- W4319443485 cites W2009219530 @default.
- W4319443485 cites W2011234714 @default.
- W4319443485 cites W2013394982 @default.
- W4319443485 cites W2017597735 @default.
- W4319443485 cites W2018702616 @default.
- W4319443485 cites W2021116311 @default.
- W4319443485 cites W2022075549 @default.
- W4319443485 cites W2022540958 @default.
- W4319443485 cites W2025702999 @default.
- W4319443485 cites W2026184172 @default.
- W4319443485 cites W2037801848 @default.
- W4319443485 cites W2044702943 @default.
- W4319443485 cites W2044835625 @default.
- W4319443485 cites W2047759229 @default.
- W4319443485 cites W2051353597 @default.
- W4319443485 cites W2053648763 @default.
- W4319443485 cites W2055242813 @default.
- W4319443485 cites W2062783581 @default.
- W4319443485 cites W2073944569 @default.
- W4319443485 cites W2078448383 @default.
- W4319443485 cites W2079371164 @default.
- W4319443485 cites W2079394569 @default.
- W4319443485 cites W2079441029 @default.
- W4319443485 cites W2080202443 @default.
- W4319443485 cites W2080324444 @default.
- W4319443485 cites W2081549959 @default.
- W4319443485 cites W2081596239 @default.
- W4319443485 cites W2082442802 @default.
- W4319443485 cites W2088571368 @default.
- W4319443485 cites W2095003008 @default.
- W4319443485 cites W2095893831 @default.
- W4319443485 cites W2096283457 @default.
- W4319443485 cites W2098276344 @default.
- W4319443485 cites W2100413206 @default.
- W4319443485 cites W2103563357 @default.
- W4319443485 cites W2111419867 @default.
- W4319443485 cites W2117785813 @default.
- W4319443485 cites W2119896120 @default.
- W4319443485 cites W2120161817 @default.
- W4319443485 cites W2123667136 @default.
- W4319443485 cites W2124396025 @default.
- W4319443485 cites W2128687105 @default.
- W4319443485 cites W2134878729 @default.
- W4319443485 cites W2137910932 @default.
- W4319443485 cites W2138464015 @default.
- W4319443485 cites W2139977061 @default.
- W4319443485 cites W2140069170 @default.
- W4319443485 cites W2145267522 @default.
- W4319443485 cites W2150990488 @default.
- W4319443485 cites W2152061559 @default.
- W4319443485 cites W2152497936 @default.
- W4319443485 cites W2154670252 @default.
- W4319443485 cites W2156906256 @default.
- W4319443485 cites W2158303916 @default.
- W4319443485 cites W2163035374 @default.
- W4319443485 cites W2275872217 @default.
- W4319443485 cites W2291932235 @default.
- W4319443485 cites W2294927533 @default.
- W4319443485 cites W2319723158 @default.
- W4319443485 cites W2319962899 @default.
- W4319443485 cites W2329962575 @default.
- W4319443485 cites W2331596320 @default.
- W4319443485 cites W2340636398 @default.